CLINICAL IMMUNOLOGY
STAT4 gene polymorphism in patients after renal allograft transplantation
Submission date: 2016-04-05
Final revision date: 2016-06-01
Acceptance date: 2016-06-01
Publication date: 2016-10-25
Cent Eur J Immunol 2016;41(3):255-259
KEYWORDS
ABSTRACT
Introduction: STAT4 (signal transducer and activator of transcription 4) is involved in the regulation of innate and adaptive immune responses. Some studies have suggested that STAT4 may be involved in the immune response after graft transplantation. Several polymorphisms in the STAT4 gene have been identified. The most commonly studied polymorphism in the STAT4 gene is rs7574865. In our study, we examined whether this polymorphism is associated with the early and late functions of renal allografts.
Material and methods: A total of 270 recipients of first renal transplants were included in the study. Single nucleotide polymorphisms (SNPs) within the STAT4 gene were genotyped using TaqMan genotyping assays.
Results: There were no statistically significant associations between the STAT4 gene rs7574865 polymorphism and delayed graft function, acute rejection, chronic allograft dysfunction, post-transplant diabetes mellitus, or creatinine serum concentrations after transplantation.
Conclusions: Our results suggest a lack of association between the STAT4 rs7574865 SNP and kidney allograft function in the Polish population.
Material and methods: A total of 270 recipients of first renal transplants were included in the study. Single nucleotide polymorphisms (SNPs) within the STAT4 gene were genotyped using TaqMan genotyping assays.
Results: There were no statistically significant associations between the STAT4 gene rs7574865 polymorphism and delayed graft function, acute rejection, chronic allograft dysfunction, post-transplant diabetes mellitus, or creatinine serum concentrations after transplantation.
Conclusions: Our results suggest a lack of association between the STAT4 rs7574865 SNP and kidney allograft function in the Polish population.
REFERENCES (27)
1.
Turkson J (2004): STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets 8: 409-422.
2.
Kaplan MH (2005): STAT4: a critical regulator of inflammation in vivo. Immunol Res 31: 231-242.
3.
Levy DE, Darnell JE Jr (2002): Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
4.
O’Malley JT, Sehra S, Thieu VT, et al. (2009): Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells. Immunology 127: 587-595.
5.
Nakayamada S, Kanno Y, Takahashi H, et al. (2011): Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35: 919-931.
6.
Watford WT, Hissong BD, Bream JH, et al. (2004): Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 202: 139-156.
7.
Bi C, Li B, Cheng Z, et al. (2013): Association study of STAT4 polymorphisms and type 1 diabetes in Northeastern Chinese Han population. Tissue Antigens 81: 137-140.
8.
Remmers EF, Plenge RM, Lee AT, et al. (2007): STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357: 977-986.
9.
Liu QF, Li Y, Zhao QH, et al. (2015): Association of STAT4 rs7574865 polymorphism with susceptibility to inflammatory bowel disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 39: 627-636.
10.
Korman BD, Kastner DL, Gregersen PK, et al. (2008): STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8: 398-403.
11.
Korman BD, Alba MI, Le JM, et al. (2008): Variant form of STAT4 is associated with primary Sjögren’s syndrome. Genes Immun 9: 267-270.
12.
Lu X, Perkins DL (2005): A systems biology view of allograft rejection. Curr Opin Organ Transpl 10: 28-34.
13.
Solez K, Colvin RB, Racusen LC, et al. (2008): Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8: 753-760.
14.
Davidson J, Wilkinson A, Dantal J, et al. (2003): New-onsetdiabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75: S3-24.
15.
Huang Y, Lei Y, Zhang H, et al. (2011): MicroRNA reulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells. Blood 118: 6793-6802.
16.
Chang JS, Wiemels JL, Chokkalingam AP, et al. (2010): Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 19: 2152-2163.
17.
Chang HC, Han L, Goswami R, et al. (2009): Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood 113: 5887-5890.
18.
Liang Y, Christopher K, DeFina R, et al. (2003): Analysis of cytokine functions in graft rejection by gene expression profiles. Transplantation 76: 1749-1758.
19.
Zhou P, Szot GL, Guo Z, et al. (2000): Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol 165: 5580-5587.
20.
Eurich D, Boas-Knoop S, Struecker B, et al. (2013): Genetic variants of STAT-4 affect the development of graft fibrosis after liver transplantation for HCV-induced liver disease. Transplantation 95: 203-208.
21.
Shuai K, Liu B (2003): Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3: 900-911.
22.
Zervou MI, Mamoulakis D, Panierakis C, et al. (2008): STAT4: a risk factor for type 1 diabetes? Hum Immunol 69: 647-450.
23.
Lee HS, Park H, Yang S, et al. (2008): STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes. Ann N Y Acad Sci 1150: 93-98.
24.
Yi J, Fang X, Wan Y, et al. (2015): STAT4 polymorphisms and diabetes risk: a meta-analysis with 18931 patients and 23833 controls. Int J Clin Exp Med 8: 3566-3572.
25.
Li C, Zhao L, Wang W, et al. (2015): STAT4 rs7574865 polymorphism contributes to the risk of type 1 diabetes: a meta analysis. Int J Clin Exp Med 8: 2471-2475.
26.
Bolin K, Sandling JK, Zickert A, et al. (2013): Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS One 8: e84450.
27.
Yang H, Zhou Q, Chen ZM, et al. (2011): Polymorphisms in STAT4 increase the risk of acute renal allograft rejection in the Chinese population. Transpl Immunol 24: 216-219.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
